Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response
Journal of Virology · 2026
DOI: 10.1128/jvi.02202-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Virology, 2026. Verfasst von Swarandeep Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV-1, env Gene Products, Human Immunodeficiency Virus, HIV Antibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Despite decades of intensive research, a protective prophylactic HIV-1 vaccine remains elusive. Considerable efforts have been made in developing HIV-1 vaccines which are capable of neutralizing diverse clades by utilizing conserved epitopes on the HIV-1 envelope glycoprotein (Env). However, traditional Env immunogens typically elicit only clade-specific neutralizing antibodies (nAbs), underscoring the need for novel strategies to trigger rare B cell precursors and then steer affinity maturation toward broadly neutralizing antibody (bnAb) induction. In recent years, diverse innovative vaccine antigen design strategies have been explored to induce protective bnAb response. In this review, we discuss the key technological advances in Env-based vaccine design, emerging immunization strategies, and insights from the recent clinical trials. It further provides a unique perspective on pediatric/infant-derived immunogen strategies. Ongoing collaborative efforts in rational immunogen design, optimized delivery strategies, and strategic immunization regimens will be critical for developing a vaccine capable of eliciting durable protective bnAb responses against HIV-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
- Emory Vaccine Centre Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
ORCID-Profile: Swarandeep Singh, Sanjeev Kumar, Kalpana Luthra
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Singh, S., Kumar, S., & Luthra, K. (2026). Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. Journal of Virology. https://doi.org/10.1128/jvi.02202-25
Vancouver
Singh S, Kumar S, Luthra K. Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. Journal of Virology. 2026. doi:10.1128/jvi.02202-25
BibTeX
@article{Singh2026,
author = {Singh, Swarandeep and Kumar, Sanjeev and Luthra, Kalpana},
title = {Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.02202-25}
}
EUVIMED